| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.19 | 1e-09 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.19 | 3e-07 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.22 | 5e-06 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.19 | 3e-05 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.13 | 5e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.21 | 6e-05 |